[ Price : $8.95]
FDA issues Savara a Refusal-to-File (RTF) letter for its BLA for Molbreevi (molgramostim) inhalation solution for treating autoimm...[ Price : $8.95]
FDA grants an expanded interchangeable designation for Celltrions Yuflyma (adalimumab-aaty), a biosimilar copy of AbbVies Humira. ...[ Price : $8.95]
BD recalls its Esophagogastric Balloon Tamponade Tubes to update the devices instructions for use due to difficulties in removing ...[ Price : $8.95]
FDA approves Liquidias Yutrepia (Treprostinil), a new inhalation powder designed to treat adults with pulmonary arterial hypertens...[ Price : $8.95]
FDA approves Roches Susvimo (ranibizumab injection) 100 mg/mL for treating diabetic retinopathy.[ Price : $8.95]
FDA advises Covid-19 vaccine makers to formulate their products to match the currently circulating JN.1-lineage and preferentially...[ Price : $8.95]
Gilead Sciences reports promising results from its Phase 3 ASCENT-03 trial evaluating Trodelvy (sacituzumab govitecan-hziy) in pat...[ Price : $8.95]
A federal judge extends by two weeks a preliminary injunction halting the Trump administrations plans for further reductions in fo...